Specialized Care: For patients with type 2 diabetes, we provide blood sugar monitoring and medication adjustments to maintain control
Be prepared to take detailed notes
This case thus exhibits reported karyotypic changes overlapping MMNST, MPNST, and schwannoma (8q gain, and 1p, 17p, and 22q loss), and MMNST and melanoma (6p and 8q gains) (Figure 5A)
2 Materials and methods 2.1 Protocol and registration This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Supplementary Table S1
An alternative are anti-diabetic agents such as the GLP-1 mimetics which have been developed to normalise insulin signalling in diabetic patients with great success
Oral GLP-1s (Lillys paltusotine-orforglipron, etc.) are expected in late 2025/2026, and might be covered differently (some plans treat orals less restrictively than injectables)